Physician profile
Pushpendra Sharma
NPI 1154542603
$751.02
in general payments reported to CMS, 2019-2025
13 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.16 · 2020: $35.92 · 2021: $104 · 2022: $144 · 2023: $195 · 2024: $92.14 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $213.68 | 2019-2025 | Shingrix, Bexsero, Arexvy |
| Cranial Technologies, INC | $119.85 | 2020-2025 | Doc Band |
| Hologic Sales and Service, LLC | $81.38 | 2021-2025 | Aptima |
| Merck Sharp & Dohme LLC | $78.48 | 2023-2024 | Vaxelis, Gardasil 9, Vaxneuvance |
| Novartis Pharmaceuticals Corporation | $49.37 | 2022-2023 | |
| Novo Nordisk INC | $40.21 | 2022-2023 | Saxenda, Wegovy |
| Alk-Abello, INC | $36.39 | 2024-2025 | Grastek, Odactra, Ragwitek |
| Sanofi Pasteur INC. | $30.01 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.77 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.00 | 2021 | |
| Pfizer INC. | $19.92 | 2023 | |
| Cipher Pharmaceuticals US LLC | $18.07 | 2025 | Natroba, Spinosad |
| Scilex Pharmaceuticals INC. | $14.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pushpendra Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.